| Literature DB >> 35407693 |
Hasan Türkez1, Mehmet Enes Arslan2, Arzu Tatar3, Özlem Özdemir2, Erdal Sönmez4, Kenan Çadirci5, Ahmet Hacimüftüoğlu6, Bahattin Ceylan1, Metin Açikyildiz7, Cigdem Yuce Kahraman8, Fatime Geyikoğlu9, Abdulgani Tatar8, Adil Mardinoglu10,11.
Abstract
Titanium diboride (TiB2) and zinc borate (Zn3BO6) have been utilized in wide spectrum industrial areas because of their favorable properties such as a high melting point, good wear resistance, high hardness and thermal conductivity. On the other hand, the biomedical potentials of TiB2 and Zn3BO6 are still unknown because there is no comprehensive analysis that uncovers their biocompatibility features. Thus, the toxicogenomic properties of TiB2 and Zn3BO6 nanoparticles (NPs) were investigated on human primary alveolar epithelial cell cultures (HPAEpiC) by using different cell viability assays and microarray analyses. Protein-Protein Interaction Networks Functional Enrichment Analysis (STRING) was used to associate differentially expressed gene probes. According to the results, up to 10 mg/L concentration of TiB2 and Zn3BO6 NPs application did not stimulate a cytotoxic effect on the HPAEpiC cell cultures. Microarray analysis revealed that TiB2 NPs exposure enhances cellular adhesion molecules, proteases and carrier protein expression. Furthermore, Zn3BO6 NPs caused differential gene expressions in the cell cycle, cell division and extracellular matrix regulators. Finally, STRING analyses put forth that inflammation, cell regeneration and tissue repair-related gene interactions were affected by TiB2 NPs application. Zn3BO6 NPs exposure significantly altered inflammation, lipid metabolism and infection response activator-related gene interactions. These investigations illustrated that TiB2 and Zn3BO6 NPs exposure may affect different aspects of cellular machineries such as immunogenic responses, tissue regeneration and cell survival. Thus, these types of cellular mechanisms should be taken into account before the use of the related NPs in further biomedical applications.Entities:
Keywords: human primary alveolar epithelial cell cultures; in vitro; nanoparticles; titanium diboride; toxicogenomic responses; zinc borate
Year: 2022 PMID: 35407693 PMCID: PMC9000154 DOI: 10.3390/ma15072359
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Figure 1Characterization of titanium diboride (TiB2) NPs. (a) scanning electron microscope (SEM) analysis of TiB2 NPs, (b) transmission electron microscope (TEM) analysis of TiB2 NPs and (c) X-ray crystallography (XRD) analysis of TiB2 NPs.
Figure 2Characterization of zinc borate (Zn3BO6) NPs. (a) scanning electron microscope (SEM) analysis of Zn3BO6 NPs, (b) transmission electron microscope (TEM) analysis of Zn3BO6 NPs and (c) X-ray crystallography (XRD) analysis of Zn3BO6 NPs.
Figure 3Cell viability assay of titanium diboride (TiB2) NPs on human pulmonary alveolar cells. (a) 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell viability analysis of TiB2 NPs, (b) lactate dehydrogenase (LDH) cytotoxicity analysis TiB2 NPs and (c) neutral red (NR) cell viability analysis of TiB2 NPs on human pulmonary alveolar cells. * SPSS program, Duncan’s test was performed for each experiment for statistical calculations at a significance level ≤ 0.05.
Figure 4Cell viability assay of zinc borate (Zn3BO6) NPs on human pulmonary alveolar cells. (a) 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell viability analysis of Zn3BO6 NPs, (b) lactate dehydrogenase (LDH) cytotoxicity analysis Zn3BO6NPs and (c) neutral red (NR) cell viability analysis of Zn3BO6 NPs on human pulmonary alveolar cells. * SPSS program (SPSS®, USA), Duncan’s test was performed for each experiment for statistical calculations at a significance level ≤ 0.05.
Gene expression changes with respect to titanium diboride (TiB2) NPs application.
| Titanium Diboride | |||
|---|---|---|---|
| Upregulated Expressions | FC | Downregulated Expressions | FC |
| CXCL5 | 1.81 | FOS | −1.88 |
| GINS4 | 1.80 | MGC24103 | −1.69 |
| MMP3 | 1.67 | LOC100132564 | −1.67 |
| ANXA10 | 1.53 | MXRA5 | −1.58 |
| PTGS2 | 1.50 | RPS29 | −1.57 |
| PTGS2 | 1.47 | FOSB | −1.52 |
| BEX2 | 1.47 | INMT | −1.51 |
| CXCL5 | 1.45 | LOC100134259 | −1.50 |
| NEBL | 1.41 | MGC4677 | −1.50 |
| SERPINB2 | 1.41 | LOC728499 | −1.47 |
| IL13RA2 | 1.41 | FAM65C | −1.46 |
| DIRAS3 | 1.40 | C7orf54 | −1.45 |
| ASNS | 1.40 | BAALC | −1.41 |
| NGDN | 1.39 | STARD13 | −1.41 |
| CRLF1 | 1.38 | IFIT1 | −1.40 |
| PTPRH | 1.37 | SOCS3 | −1.39 |
| LOC143666 | 1.34 | PDGFRB | −1.38 |
| ICAM1 | 1.34 | TNFRSF11B | −1.37 |
| AGTR1 | 1.33 | HEYL | −1.37 |
| LOC100008588 | 1.32 | EGR3 | −1.37 |
| RPP25 | 1.32 | WDR33 | −1.36 |
| DDX52 | 1.32 | NEDD9 | −1.36 |
| LOC441253 | 1.32 | CRIP1 | −1.36 |
| RRAD | 1.32 | NDRG4 | −1.34 |
| SLC8A3 | 1.31 | HIST2H2BE | −1.34 |
Figure 5String analysis of titanium diboride (TiB2) NPs.
Gene expression changes with respect to zinc borate (Zn3BO6) NPs application.
| Zinc Borate | |||
|---|---|---|---|
| Upregulated Expressions | FC | Downregulaed Expressions | FC |
| APOE | 22.44 | NPTX1 | −15.36 |
| ADH1A | 20.48 | SERPINB2 | −6.68 |
| IGFBP3 | 16.88 | ESM1 | −6.55 |
| IGFBP3 | 15.34 | SERPINB2 | −5.80 |
| CFD | 14.08 | LOC728285 | −5.54 |
| PTGDS | 13.67 | MMP1 | −4.63 |
| MFAP4 | 13.41 | CCL2 | −4.57 |
| RGS4 | 12.28 | NPTX1 | −4.57 |
| SERPINA3 | 11.94 | ESM1 | −4.48 |
| CXCL12 | 10.54 | INSIG1 | −4.45 |
| FOS | 10.25 | NPTX1 | −4.28 |
| PARM1 | 9.60 | KRT19 | −4.27 |
| AMPH | 9.38 | LOC100134073 | −4.16 |
| ANGPT1 | 8.62 | KRT34 | −4.12 |
| A2M | 8.47 | H2AFY2 | −4.09 |
| CXCL12 | 8.31 | LOC728255 | −4.08 |
| CHL1 | 7.68 | GPR68 | −4.04 |
| HSD17B2 | 7.58 | TNFSF4 | −3.94 |
| FMO2 | 7.50 | E2F7 | −3.92 |
| CFTR | 7.47 | HMGCS1 | −3.87 |
| H19 | 7.40 | RGMB | −3.77 |
| CHI3L1 | 7.39 | SC4MOL | −3.74 |
| FOSB | 7.37 | MMP3 | −3.73 |
| CORO6 | 7.36 | TMEM166 | −3.69 |
| FER1L4 | 7.32 | TNFSF4 | −3.68 |
Figure 6String analysis of zinc borate (Zn3BO6) NPs.